Skip to main content
Research project

CTU - CCTG- Crabb - A RANDOMIZED PHASE II TRIAL ASSESSING TRIMODALITY THERAPY WITH OR WITHOUT ADJUVANT DURVALUMAB TO TREAT PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER

Staff

Lead researcher

Professor Gareth Griffiths

Director Clinical Trials Unit
Connect with Gareth
Other researchers

Professor Simon Crabb PhD, BSc, MBBS, MRCP

Professor of Exp'tl Cancer Therapeutics

Research interests

  • Bladder cancer
  • Prostate cancer
  • Predictive biomarkers
Connect with Simon

Collaborating research institutes, centres and groups

Research outputs